CogState Ltd
ASX:CGS

Watchlist Manager
CogState Ltd Logo
CogState Ltd
ASX:CGS
Watchlist
Price: 0.965 AUD -2.53% Market Closed
Market Cap: 166.7m AUD
Have any thoughts about
CogState Ltd?
Write Note

CogState Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CogState Ltd
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
CogState Ltd
ASX:CGS
Income from Continuing Operations
$5.4m
CAGR 3-Years
1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
4DMedical Ltd
ASX:4DX
Income from Continuing Operations
-AU$36m
CAGR 3-Years
-19%
CAGR 5-Years
-41%
CAGR 10-Years
N/A
Pro Medicus Ltd
ASX:PME
Income from Continuing Operations
AU$82.8m
CAGR 3-Years
39%
CAGR 5-Years
34%
CAGR 10-Years
49%
Medibio Ltd
ASX:MEB
Income from Continuing Operations
-AU$3.1m
CAGR 3-Years
7%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Medadvisor Ltd
ASX:MDR
Income from Continuing Operations
AU$792.1k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Alcidion Group Ltd
ASX:ALC
Income from Continuing Operations
-AU$8.4m
CAGR 3-Years
-55%
CAGR 5-Years
-151%
CAGR 10-Years
-50%
No Stocks Found

CogState Ltd
Glance View

Market Cap
164.8m AUD
Industry
Health Care

Cogstate Ltd. is a global cognitive science company. The firm provides computerized cognitive tests across various domains and support electronic clinical outcome assessment (eCOA) solutions. The firm's segment includes Clinical trials, Healthcare and Research. In the Clinical trials segment, the Company's technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians to assess cognitive decline. Research segment offers various research studies and academic collaborations across various indication of diseases.

CGS Intrinsic Value
1.607 AUD
Undervaluation 40%
Intrinsic Value
Price

See Also

What is CogState Ltd's Income from Continuing Operations?
Income from Continuing Operations
5.4m USD

Based on the financial report for Jun 30, 2024, CogState Ltd's Income from Continuing Operations amounts to 5.4m USD.

What is CogState Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 3Y
1%

Over the last year, the Income from Continuing Operations growth was 53%. The average annual Income from Continuing Operations growth rates for CogState Ltd have been 1% over the past three years .

Back to Top